Corewell Health Southfield and Quest Diagnostics have completed a previously announced transaction to establish a laboratory ...
Quest Diagnostics has rolled out an ultrasensitive blood test to monitor multiple myeloma treatment, potentially sparing patients from more invasive and costly bone marrow aspirations. | Quest ...
Quest Diagnostics recently unveiled a suite of advanced diagnostics and support services designed to broaden access to lab tests for transplants. Quest hopes to improve testing compliance among ...
Medical Device Network on MSN
Quest launches flow cytometry MRD test for myeloma
Quest expects the new blood test will support response monitoring in clinical trials.
If you have been wondering whether Quest Diagnostics at around US$185 per share is a fair deal or a stretch, you are not alone. The stock has returned 0.5% over the last 7 days, 6.5% over the past ...
Quest Diagnostics completed its acquisition of select assets from Fresenius Medical Care’s laboratory business. As part of the transaction, the Secaucus-based testing provider will now offer ...
SECAUCUS, N.J. and INDIANAPOLIS, Aug. 3, 2020 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has completed its ...
Quest Diagnostics reaffirmed as a buy: organic growth, macro demand, strong margins, investment-grade ratings, and dividend ...
A woman thinks her routine blood tests are behind her when she receives an explanation of benefits showing zero patient ...
[Updated 5/15/2020] Is Quest Diagnostics Or LabCorp The Better Diagnostic Play In The COVID Era? As the U.S. re-opens its economy while trying to contain the spread of the contagious viral infection, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results